Tetsuo Shinozaki

Papers

Total Citations

H-Index

About

Tetsuo Shinozaki is a distinguished urological oncologist whose research centers on improving outcomes for patients with high-risk and locally advanced prostate cancer. His most cited work investigates the factors predicting biochemical recurrence after radical prostatectomy in patients with clinical T3 prostate cancer, a challenging subgroup where optimal management remains debated. By retrospectively analyzing over 1,400 patients, Shinozaki identified key clinical and pathological variables—such as Gleason score, surgical margin status, and lymph node involvement—that stratify recurrence risk, offering surgeons a more precise framework for postoperative surveillance and adjuvant therapy decisions. This study, published in 2018, has garnered 3 citations and contributes to a growing evidence base that supports radical prostatectomy as a viable, potentially curative option even for non-organ-confined disease. Shinozaki’s work bridges a critical gap in urologic oncology, helping to refine patient selection and counseling. His research underscores a commitment to translating large-scale retrospective data into actionable clinical insights, making him a valuable voice in the ongoing effort to personalize treatment for men with aggressive prostate cancer.